Our in vivo models are established by transplanting sub-cutaneous human myeloma cell lines into immunocompromised mice typically SCID-Beige mice.
Choosing Myelomax means you will be able to:
Typical in vivo protocol:
- Model selection
- Injection of human myeloma cells into immunodeficient mice
- Bodyweight and behavioral monitoring
- Tumor volume monitoring
- Samples for subsequent studies: e.g. serum, blood, tumor tissue
- Tumor tissue analysis: e.g. Western Blot, qPCR
Advance your multiple myeloma research and develop programs by understanding not only how target candidates perform in vitro, but also at next stage in vivo animal models. Myelomax is dedicated to Multiple Myeloma and continuously invests to expand not only our cell lines but also our animal models.